{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T22:15:01Z","timestamp":1792275301794,"version":"4.4.0"},"reference-count":26,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009227","name":"Department of Medicine, University of Toronto","doi-asserted-by":"publisher","award":["Gabor Zellerman Chair in Nephrology Research"],"award-info":[{"award-number":["Gabor Zellerman Chair in Nephrology Research"]}],"id":[{"id":"10.13039\/501100009227","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000191","name":"Kidney Foundation of Canada","doi-asserted-by":"publisher","award":["Pearson family support"],"award-info":[{"award-number":["Pearson family support"]}],"id":[{"id":"10.13039\/501100000191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020307","name":"Toronto General Hospital Research Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100020307","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["Strategy for Patient-Oriented Research, grant numb"],"award-info":[{"award-number":["Strategy for Patient-Oriented Research, grant numb"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Can J Kidney Health Dis"],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Glomerulonephritis (GN) is a leading cause of kidney failure and accounts for 20% of incident cases of end-stage kidney disease (ESKD) in Canada annually. Reversal of kidney injury and prevention of progression to kidney failure is possible; however, limited knowledge of underlying disease mechanisms and lack of noninvasive biomarkers and therapeutic targets are major barriers to successful therapeutic intervention. Multicenter approaches that link longitudinal clinical and outcomes data with serial biologic specimen collection would help bridge this gap.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>To establish a national, patient-centered, multidimensional web-based clinical database and federated virtual biobank to conduct human-based molecular and clinical research in GN in Canada.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design:<\/jats:title>\n                    <jats:p>Multicenter, prospective observational registry, starting in 2019.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting:<\/jats:title>\n                    <jats:p>Nine participating Canadian tertiary care centers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients:<\/jats:title>\n                    <jats:p>Adult patients with a histopathologic pattern of injury consistent with IgA nephropathy, focal and segmental glomerulosclerosis, minimal change disease, membranous nephropathy, C3 glomerulopathy, and membranoproliferative GN recruited within 24 months of biopsy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Measurements:<\/jats:title>\n                    <jats:p>Initial visits include detailed clinical, histopathological, and laboratory data collection, blood, urine, and tonsil swab biospecimen collection, and a self-administered quality of life questionnaire. Follow-up clinical and laboratory data collection, biospecimen collection, and questionnaires are obtained every 6 months thereafter.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Patients receive care as defined by their physician, with study visits scheduled every 6 months. Patients are followed until death, dialysis, transplantation, or withdrawal from the study. Key outcomes include a composite of ESKD or a 40% decline in estimated glomerular filtration rate (eGFR) at 2 years, rate of kidney function decline, and remission of proteinuria. Clinical and molecular phenotypical data will be analyzed by GN subtype to identify disease predictors and discover therapeutic targets.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Limitations:<\/jats:title>\n                    <jats:p>Given the relative rarity of individual glomerular diseases, one of the major challenges is patient recruitment. Initial registry studies may be underpowered to detect small differences in clinically meaningful outcomes such as ESKD or death due to small sample sizes and short duration of follow-up in the initial 2-year phase of the study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>The Canadian Glomerulonephritis Registry (CGNR) supports national collaborative efforts to study glomerular disease patients and their outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration:<\/jats:title>\n                    <jats:p>NCT03460054.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/20543581221089094","type":"journal-article","created":{"date-parts":[[2022,4,8]],"date-time":"2022-04-08T05:27:45Z","timestamp":1649395665000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":4,"title":["The Canadian Glomerulonephritis Registry (CGNR) and Translational Research Initiative: Rationale and Clinical Research Protocol"],"prefix":"10.1177","volume":"9","author":[{"given":"Ainslie M.","family":"Hildebrand","sequence":"first","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University of Alberta, Edmonton, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moumita","family":"Barua","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University Health Network, University of Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean J.","family":"Barbour","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, The University of British Columbia, Vancouver, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7919-6709","authenticated-orcid":false,"given":"Karthik K.","family":"Tennankore","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Dalhousie University, Halifax, NS, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel C.","family":"Cattran","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University Health Network, University of Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Takano","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, McGill University, Montreal, QC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Lam","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University Health Network, University of Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sacha A.","family":"De Serres","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, CHU de Qu\u00e9bec-Universit\u00e9 Laval, Quebec City, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ratna","family":"Samanta","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, McGill University, Montreal, QC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9227-4292","authenticated-orcid":false,"given":"Michelle A.","family":"Hladunewich","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd","family":"Fairhead","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, The Ottawa Hospital, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7575-2835","authenticated-orcid":false,"given":"Penelope","family":"Poyah","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Dalhousie University, Halifax, NS, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Danielle","family":"Bush","sequence":"additional","affiliation":[{"name":"McCarthy Tetrault LLP, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"MacLaren","sequence":"additional","affiliation":[{"name":"Canadian Glomerulonephritis Registry, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dwight","family":"Sparkes","sequence":"additional","affiliation":[{"name":"Canadian Glomerulonephritis Registry, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Boll","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Trillium Health Partners, Mississauga, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5246-8324","authenticated-orcid":false,"given":"Arenn","family":"Jauhal","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University Health Network, University of Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohan","family":"John","sequence":"additional","affiliation":[{"name":"Department of Pathology, Toronto General Hospital, University Health Network, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Avila-Casado","sequence":"additional","affiliation":[{"name":"Department of Pathology, Toronto General Hospital, University Health Network, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8951-5518","authenticated-orcid":false,"given":"Heather N.","family":"Reich","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University Health Network, University of Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2022,4,8]]},"reference":[{"key":"bibr1-20543581221089094","unstructured":"Canadian Institute for Health Information. Treatment of End-Stage Organ Failure in Canada, Canadian Organ Replacement Register, 2009 to 2018: End-Stage Kidney Disease and Kidney Transplants\u2014Data Tables. Ottawa, ON: Canadian Institute for Health Information; 2019."},{"key":"bibr2-20543581221089094","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfq665"},{"issue":"2","key":"bibr3-20543581221089094","first-page":"158","volume":"124","author":"Cattran DC","year":"1981","journal-title":"Can Med Assoc J"},{"key":"bibr4-20543581221089094","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2369-14-236"},{"key":"bibr5-20543581221089094","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2018.07.020"},{"key":"bibr6-20543581221089094","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2012.428"},{"key":"bibr7-20543581221089094","first-page":"j3453","volume":"358","author":"Staniszewska S","year":"2017","journal-title":"Res Involv Engagem"},{"key":"bibr8-20543581221089094","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2005.01.008"},{"key":"bibr9-20543581221089094","unstructured":"CanVasc: Canadian network for research on vasculitides. www.canvasc.ca\/index.html. Accessed January 22, 2021."},{"issue":"2","key":"bibr10-20543581221089094","first-page":"139","volume":"2012","author":"KDIGO clinical practice guideline for glomerulonephritis KDIGO clinical practice guideline for glomerulonephritis KDIGO clinical practice guideline for glomerulonephritis","journal-title":"Kidney Inter"},{"key":"bibr11-20543581221089094","doi-asserted-by":"publisher","DOI":"10.1007\/BF00451725"},{"key":"bibr12-20543581221089094","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2020.09.038"},{"key":"bibr13-20543581221089094","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000100125.21491.46"},{"key":"bibr14-20543581221089094","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.13651215"},{"key":"bibr15-20543581221089094","doi-asserted-by":"publisher","DOI":"10.1177\/2054358117753617"},{"key":"bibr16-20543581221089094","doi-asserted-by":"publisher","DOI":"10.1016\/j.semnephrol.2015.04.001"},{"key":"bibr17-20543581221089094","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.13231215"},{"issue":"2","key":"bibr18-20543581221089094","first-page":"158","volume":"124","author":"Regional program for the study of glomerulonephritis","year":"1981","journal-title":"Can Med Assoc J"},{"key":"bibr19-20543581221089094","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-017-0669-4"},{"key":"bibr20-20543581221089094","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0810457"},{"key":"bibr21-20543581221089094","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2016.01.030"},{"key":"bibr22-20543581221089094","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2014.48"},{"key":"bibr23-20543581221089094","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfz028"},{"key":"bibr24-20543581221089094","doi-asserted-by":"publisher","DOI":"10.1038\/ng1161"},{"key":"bibr25-20543581221089094","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32597-8"},{"key":"bibr26-20543581221089094","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1908639"}],"container-title":["Canadian Journal of Kidney Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/20543581221089094","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/20543581221089094","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/20543581221089094","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T15:24:14Z","timestamp":1777389854000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/20543581221089094"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":26,"alternative-id":["10.1177\/20543581221089094"],"URL":"https:\/\/doi.org\/10.1177\/20543581221089094","relation":{},"ISSN":["2054-3581","2054-3581"],"issn-type":[{"value":"2054-3581","type":"print"},{"value":"2054-3581","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1]]},"article-number":"20543581221089094"}}